Using GRADE methodology for the development of public health guidelines for the prevention and treatment of HIV and other STIs among men who have sex with men and transgender people by Elie A Akl et al.
Akl et al. BMC Public Health 2012, 12:386
http://www.biomedcentral.com/1471-2458/12/1/386CORRESPONDENCE Open AccessUsing GRADE methodology for the development
of public health guidelines for the prevention and
treatment of HIV and other STIs among men who
have sex with men and transgender people
Elie A Akl1,2*, Caitlin Kennedy3, Kelika Konda4, Carlos F Caceres5, Tara Horvath6, George Ayala7, Andrew Doupe8,
Antonio Gerbase9, Charles Shey Wiysonge10, Eddy R Segura11, Holger J Schünemann2 and Ying-Ru Lo9Abstract
Background: The World Health Organization (WHO) Department of HIV/AIDS led the development of public health
guidelines for delivering an evidence-based, essential package of interventions for the prevention and treatment of
HIV and other sexually transmitted infections (STIs) among men who have sex with men (MSM) and transgender
people in the health sector in low- and middle-income countries. The objective of this paper is to review the
methodological challenges faced and solutions applied during the development of the guidelines.
Methods: The development of the guidelines followed the WHO guideline development process, which utilizes the
GRADE approach. We identified, categorized and labeled the challenges identified in the guidelines development
process and described the solutions through an interactive process of in-person and electronic communication.
Results: We describe how we dealt with the following challenges: (1) heterogeneous and complex interventions;
(2) paucity of trial data; (3) selecting outcomes of interest; (4) using indirect evidence; (5) integrating values and
preferences; (6) considering resource use; (7) addressing social and legal barriers; (8) wording of recommendations;
and (9) developing global guidelines.
Conclusion: We were able to successfully apply the GRADE approach for developing recommendations for public
health interventions. Applying the general principles of the approach while carefully considering specific challenges
can enhance both the process and the outcome of guideline development.Background
The human immunodeficiency virus (HIV) epidemic is dis-
proportionately affecting men who have sex with men
(MSM) and transgender people in low- and middle-income
countries [1,2], as well as in high-income countries [3].
These populations are similarly at higher risk of Chlamydia
trachomatis and Neisseria gonorrhea infections relative to
the general population [4]. Addressing the HIV epidemic in
these specific populations at the global level is essential to
control and reverse the epidemic in the general population.* Correspondence: elieakl@buffalo.edu
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reproduction in any medium, provided the orThe WHO Department of HIV/AIDS was charged
with the development of guidelines for delivering an
evidence-based, essential package of interventions for
the prevention and treatment of HIV and other sexually
transmitted infections (STIs) among MSM and trans-
gender people in the health sector in low- and middle-
income countries [5].
WHO’s guideline development process [6] uses the
Grades of Recommendation, Assessment, Development,
and Evaluation (GRADE) approach [7]. There has been
substantial debate about the best grading framework in
the field of public health [8-11]. Our experience develop-
ing guidelines is a useful case study providing lessons
learned and insights into the use of GRADE in the de-
velopment of public health guidelines. It would also. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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health systems and policymaking. The objective of this
paper is to review the methodological challenges faced




GRADE presents a systematic and transparent framework
for clarifying questions, determining the outcomes of inter-
est, summarizing the evidence that addresses a question,
and moving from the evidence to a recommendation or
decision [12-14]. Additional file 1 and Additional file 2
respectively present GRADE definitions, categories, and
factors affecting the quality of evidence and the strength
of recommendation [15,16]. GRADE is currently the
most widely accepted and used framework for develop-
ing guidelines. More than 50 organizations worldwide,
many highly influential, have endorsed the framework
(http://www.gradeworkinggroup.org/).
Guideline development
A core working group consisted of community repre-
sentatives, content experts, systematic reviewers and a
guideline methodologist. The group initially drafted
specific guideline questions following the PICO for-
mat (PICO refers to Population, Intervention, Com-
parison, Outcomes) [17]. For each of the PICO
questions, the working group conducted systematic
reviews and developed GRADE evidence profiles to
summarize the evidence and rate the quality of evi-
dence [12-14] (Additional file 3: example of an evi-
dence profile) [7].
The core working group held three face to face work-
ing meetings in preparation for the final consensus
meeting. For the final consensus meeting, the core work-
ing group developed for each PICO question a decision
table summarizing judgments about: the quality of evi-
dence, the balance of benefits and harms, values and
preferences, resource use, and feasibility (Additional file
3: example of a decision table) [12]. The final consensus
meeting was held in Beijing, China in September 2010.
The consensus panel consisted of community represen-
tatives, content experts, systematic reviewers, a method-
ologist, and national HIV/AIDS and STI program
managers. Community representatives were members of
the core working group and the consensus panel. The
guidelines were published in June 2011 [18].
Here are the interventions addressed by the guidelines:
1. Condom use, and serosorting
2. Adult male circumcision
3. Human papilloma virus (HPV) and hepatitis A and
B vaccination;4. Periodic testing for asymptomatic STIs and STI
syndromic management;
5. Behavioral interventions (individual, group and
community levels);
6. HIV testing and counseling;
7. Use of outreach, social marketing and the internet to
reach target constituencies;
8. Complementary mental health interventions to
address substance use, and harm reduction programs
among injection drug users and among transgender
people who undertake gender enhancement
procedures involving the injection of substances.
Determination of the challenges
The core working group conducted discussions of meth-
odological challenges through email communications and
during the three working meetings and the final consensus
meeting. We subsequently identified, categorized and la-
beled the identified challenges. We then finalized through
an interactive process of in-person and electronic commu-
nication the solutions to these challenges along with illus-
trative examples from the guidelines.
We defined public health interventions as those target-
ing policymakers or public health professionals as well
as affected populations, and are implemented in the
form of programs. These include biomedical, behavioral,
structural, and health system interventions. Clinical
interventions target individual health consumers and
their clinicians, are implemented by individuals, and
consist mostly of biomedical interventions. Some bio-
medical interventions (e.g., screening for HIV) can be
implemented both as a public health intervention (e.g.,
HIV screening program in an STI clinic) and as a clinical
intervention (e.g., a clinician offering HIV screening to a
patient based on individual risk assessment).
Results
We have identified the following nine challenges: (1)
heterogeneous and complex interventions; (2) paucity of
trial data; (3) selecting outcomes of interest; (4) using in-
direct evidence; (5) integrating values and preferences;
(6) considering resource use; (7) addressing social and
legal barriers; (8) wording of recommendations; and (9)
developing global guidelines. We discuss below and
summarize in Table 1 each of these challenges and how
we addressed them. The order of presentation is not
related to the seriousness of the challenges. The first
four challenges relate to the grading of the quality of evi-
dence while the other five relate to the grading of the
strength of recommendation.
Heterogeneous and complex interventions
The nature of public health interventions differs from
that of most clinical interventions in a number of





• We defined a priori the classification of complex
interventions (e.g., classifying behavioral interventions
into individual, group and community levels)
• When interventions were combined, we considered
separately each component intervention to the extent
that the available evidence allowed it
Paucity of
trial data
• We considered evidence for effectiveness from
observational studies
• We used cross sectional studies to derive baseline





• We selected outcomes in a transparent and
comprehensive manner, and a priori




• For each intervention, we made judgments about the
importance of the indirectness of the population (e.g.,
when applying evidence from MSM population to a
transgender population) and of the setting (e.g., when
applying evidence from high income countries to low-
and middle-income countries)
• We downgraded the quality of evidence when




• Community representatives were involved in the
development and review of the guidelines
• We conducted a survey of community members
about the values and preferences they attach to the




• We did not consider this factor in a systematic and formal
way
• For each question, experts made judgments about




• We issued ‘good practice recommendations’ based on
the principles of medical ethics and human rights
Wording of
recommendations
• We used the term ‘conditional’
(instead of weak) for non-strong recommendation
• We explained for each recommendation what the




• The survey of values and preferences recruited
participants globally.
• We prioritized evidence of from low- and middle-
income countries when available
• The panelists prioritized the perspective of low- and
middle-income countries
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neous, complex and used in combination, public health
interventions tend to possess these characteristics more
frequently and to a larger degree [19].
We frequently identified heterogeneity in the characteris-
tics of interventions evaluated in studies. For example,
studies examining group behavioral interventions varied in
the number of participants per group, in the number of
sessions, and in the topics discussed (e.g., sexual risk be-
havior, safer sex, condom use, healthy relationships, etc.).
Our challenge was to decide whether these interven-
tions were similar enough to consider (and meta-analyze)these studies together, and to ultimately issue one or mul-
tiple recommendations. In the case of behavioral interven-
tions, we classified them a priori based on whether they
were implemented at the individual, group or behavioral
level. We faced similar difficulties with the reviews of sex
venue-based interventions, social marketing campaigns,
and Internet-based targeted interventions.
Many public health interventions are implemented in
combination with other interventions because of their
assumed synergistic effect. For example, counseling inter-
ventions are implemented along with HIV testing to im-
prove understanding and behavior change. In the field of
HIV, this has been recently discussed as combination HIV
prevention [20,21]. Furthermore, the specific combination
of interventions depends on the setting and local needs–
the “know your epidemic know your current response” ap-
proach [22].
For global guidelines, it is not practical to issue recom-
mendations for all possible combinations of interventions,
and it is very unlikely that studies addressing all different
combinations exist. Our approach was to consider separ-
ately each individual intervention to the extent that the
available evidence allowed this. The aim was to provide a
menu of effective individual interventions for policy-
makers to choose from according to their local conditions
and need. The main limitations to this approach are po-
tentially missing any synergistic effect, and dealing with
evidence assessing combinations of interventions.
Another methodological challenge associated with the
evaluation of these interventions is the risk of contamin-
ation (e.g., with information diffusion interventions) and
the need for cluster randomized trials [23]. Also, the
success of some of these interventions depends on the
individuals implementing them (e.g., behavioral change
interventions), requiring careful evaluation methods [24].
Paucity of trial data
The scarcity of trial data and using non-trial data were a matter
of debate during our guideline development process, as they
have been for others involved in guideline development [25].
The evidence for all but four questions came from ob-
servational studies resulting, according to the GRADE ap-
proach, (Additional file 1) [13] in ‘very low’ or ‘low’ quality
of evidence for 12 out of 15 graded recommendations.
Also, according to the GRADE approach, recommenda-
tions based on lower quality of evidence are likely to be con-
ditional, as opposed to strong (Additional file 2) [12]. Out
of the 15 grade recommendations, 10 were graded as
conditional.
Some panelists at the guidelines consensus meeting
were uncomfortable with the relatively low rating of the
quality of evidence. They argued that conducting rando-
mized controlled trials (RCTs) for public health ques-
tions might be either challenging (e.g., community level
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sible (e.g., legal interventions). Therefore, they felt that
the available evidence from non-randomized studies
should be rated higher [26-28].
However, the fact that the best available evidence comes
(or could only come) from observational study designs
does not automatically imply that these designs provide
high quality evidence. Indeed, reasons for which we have
less confidence in these designs relative to RCTs are valid
irrespective of whether trial data is (or could be) available.
In addition, observational studies could potentially pro-
vide “moderate” and even “high” quality evidence within
the GRADE framework [15]. For example, the quality of
evidence from cohort studies for the effectiveness of con-
dom use among MSM was rated up to “moderate” due to
a large effect size (relative risk of 0.34).
Panelists may have been uncomfortable with the low rat-
ing of the quality of evidence because it would likely lead to
a weak recommendation. There was a concern that policy-
makers may use both “low quality evidence” (i.e., low confi-
dence in effect estimates) and “weak recommendations” as
excuses to forgo the implementation of the recommenda-
tion. Please refer to challenge (8) on how we used wording
of recommendations to address these concerns.
Although GRADE stipulates that trial data provide the
least-biased evidence for the effects of interventions, it
does consider other types of studies. Firstly, it considers
observational studies for assessing (1) the long term and
rare effects of interventions, and (2) the effectiveness data
in the absence of trial data, which – as discussed above –
may lead to moderate or high quality evidence (Additional
file 1). It is possible that observational data could provide
higher quality evidence than poorly conducted trials.
Secondly, in order to generate accurate absolute esti-
mates of effects, GRADE calls for deriving baseline risks
of outcomes from observational studies. For example, in
assessing the absolute effects of behavioral interventions
on HIV incidence, we derived the baseline risk from cross
sectional studies appropriate for the low-, intermediate-,
and high-risk groups [29,30].
Thirdly, assessing public health interventions benefits
from a broad range of evidence, e.g., from the behavioral
and social sciences [25]. One example is the use of process
evaluation of complex interventions [31]. By capturing the
experiences of participants and the details of the implemen-
tation, qualitative and quantitative studies help evaluate the
different components of the intervention and investigate its
contextual factors (e.g., socio-cultural factors which can act
as mediators and moderators). For studies with positive
results, observational data aid in assessing transferability
[32]. Studies finding no effects can help in distinguishing
between interventions that are inherently ineffective and
those which, because of poor implementation, were not
fairly evaluated [32].Identifying process evaluation data requires additional
time and resources, a specific set of skills and expertise,
and searching outside the conventional biomedical data-
bases. Moreover, this type of evidence is not readily
available [33]. Indeed, we did not identify any process
evaluation study for any of the RCTs considered in this
guideline. This proved particularly problematic in inter-
preting the results of a group level behavioral interven-
tion that unexpectedly showed increased rates of STI
[34]. Subsequently, the panel was not able to reach a
consensus on whether to recommend group level inter-
ventions on the basis of this one study.
Selecting the outcomes of interest
Selecting important outcomes for each PICO question is
a critical step in the development of recommendations
[17], especially for public health guidelines.
The important outcomes should include all benefits
and harms of the intervention. One additional important
outcome that the panel considered was quality of life. In
fact, it is thought that MSM are using condoms less fre-
quently because it affects their sexual experience nega-
tively. Another important unintended effect that the
panel considered is discrimination [35-37].
The choice of important outcomes should be inde-
pendent of whether or not they have been empirically
assessed, while the choice of intermediate outcomes
should capture those that have been empirically
assessed. These outcomes should be selected in a trans-
parent and comprehensive manner, and a priori (i.e.,
prior to reviewing the evidence). In order to achieve
these goals, we developed an outcome framework for
each question or group of related questions (Figures 1, 2)
[38]. Each framework describes all possible pathways
between the intervention and the important outcomes.
Public health interventions can affect both individual-
level and community-level outcomes. For example, an
HIV testing and counseling intervention may affect the
timeliness of diagnosis and treatment at the individual
level, and HIV transmission at the community level
(Figure 1). In both cases, the testing intervention
would eventually affect both morbidity and mortality.
The outcome framework helped in depicting these two
distinct but convergent pathways.
The pathway for a prevention intervention has three
levels of outcomes: (1) behavioral change, (2) HIV acqui-
sition and transmission, and (3) morbidity and mortality
(Figure 2). In this pathway the outcomes of utmost im-
portance are morbidity and mortality. A conservative ap-
proach might consider these outcomes as the only
important ones. Practically, this would lead to down-
grading the quality of evidence associated with HIV ac-
quisition and transmission for indirectness, leading to
moderate quality evidence at best. The guideline panel
Figure 1 Example of an outcome framework for a testing and counseling intervention.
Akl et al. BMC Public Health 2012, 12:386 Page 5 of 9
http://www.biomedcentral.com/1471-2458/12/1/386made the judgment that HIV acquisition and transmis-
sion are relevant enough outcomes that downgrading
the quality is not warranted. This judgment was based
on the fact that a reduction in HIV transmission is
highly associated with a reduction in morbidity and mor-
tality associated with HIV infection. On the other hand,
the panel made the judgment that behavioral change is
an indirect outcome warranting downgrading the quality
of evidence.
Indirectness of the evidence
In addition to the indirectness of the outcome (see pre-
ceding paragraph), the panel dealt with the indirectness
of the population and of the setting, a concept alsoFigure 2 Example of an outcome framework for a prevention interveknown as applicability [39]. Although these guidelines
address both MSM and transgender people, we did not
identify direct evidence for transgender people. The
panel made the judgment that the indirectness of the
evidence for that population was not serious enough to
warrant downgrading its quality. However, one has to
acknowledge that the degree of indirectness varies across
the questions. For example, the evidence is likely to be
more indirect for the behavioral interventions relative to
screening interventions.
As to the setting, for many PICO questions, the avail-
able evidence came solely from high-income countries.
The judgment of the degree of indirectness depended
on the intervention. For example, the panel judgedntion.
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HIV infection is not indirect enough when applied to
low-income countries to warrant downgrading the
quality of evidence. Conversely, the panel judged that
the evidence about the effects of serosorting on HIV
infection is indirect enough to warrant downgrading
the quality of evidence, because the practice of sero-
sorting requires regular high-quality and easily access-
ible HIV testing, re-testing and counseling that is
frequently not available in low- and middle-income
countries. Guideline panels may use more formal
approaches to judging applicability [40].
Integrating values and preferences
In the GRADE framework, the values and preferences of
the target population are a major factor in determining
the direction and strength of recommendations [14]. For
these guidelines, the perspectives of MSM and trans-
gender people were incorporated in a variety of ways.
Firstly, community representatives were members of the
core working group and the final meeting consensus
panel. Secondly, two community members from a low-
income and a high-income country respectively reviewed
the final drafts of the guidelines. Thirdly, the WHO sec-
retariat commissioned the Global Forum on MSM and
HIV (GFMSM) to conduct a survey of both HIV positive
and HIV negative MSM and transgender people from
Asia, Africa and Latin America. The survey consisted of
online interviews about the values and preferences commu-
nity members attach to the outcomes and interventions
considered in the guideline questions, the implications of
the proposed guidelines, and concerns that might emerge
among them from their potential implementation. The
results of the survey were an integral part of the deci-
sion tables used, in some instances verbatim, at the
guideline consensus meeting. The working group dis-
cussed the possibility of conducting a systematic review
of studies of values and preferences relevant to the
guideline question, but did not pursue this because of
time and resource limitations.
The above approach of integrating values and prefer-
ences of the target population has resulted in the guide-
lines taking the perspective of MSM and transgender
people. The advantages of that approach include im-
proving the quality of the guidelines, and increasing
their chances of acceptance and implementation by the
MSM and transgender communities. One disadvantage
is a potential inconsistency of some of the recommen-
dations with differing set of values and preferences in
certain settings.
Considering resource use
Resource use is one factor that is considered in determining
the direction and strength of recommendations in theGRADE framework [14]. Resource use becomes particu-
larly important for guidelines targeting low- and middle-
income countries. Indeed, the availability of resources and
costs are likely to vary substantially across low- and middle
-income countries. Unfortunately, the expertise and
resources were not available for the panel to consider this
factor in a systematic and formal way. However, the deci-
sion tables for each recommendation included a judgment
about the implications of resource use. For example, con-
dom use was seen as a relatively not resource intensive
intervention. On the other hand, medical male circumci-
sion was seen as a resource-intensive intervention, particu-
larly in settings in which such programs are not being
rolled out for the general male population. This affected
the direction of the recommendation and resulted in a con-
ditional recommendation against male circumcision in
spite of low quality evidence suggesting benefits may out-
weigh harms.
Addressing social and legal barriers
Discrimination, stigma, punitive laws and law enforce-
ment practices are major barriers for MSM and trans-
gender people in accessing health services [41-43]. This
undermines the effectiveness of HIV prevention and
treatment programs, particularly in low- and middle-
income countries [44]. The panel felt a need to include a
strong recommendation to make health services inclu-
sive of MSM and transgender people, and more gener-
ally to ensure protective laws and regulations. However,
there was no direct evidence to justify a strong recom-
mendation, if one followed the typical GRADE approach.
The resolution was to frame these recommendations as
‘good practice recommendations’ – as defined by
GRADE – and base them on the principles of medical
ethics and human rights [7].
Good practice recommendations are typically those in
which desirable effects undoubtedly outweigh any un-
desirable ones so that conducting a study addressing the
implicit question could not be justified [7]. Indeed, a test
of whether a recommendation qualifies as a ‘good prac-
tice recommendation’ is to check whether the alternative
sounds bizarre or ridiculous. GRADE suggests using
‘good practice recommendations’ for interventions that
represent “necessary and standard procedures of the
clinical encounter or health care system” [7].
Here are the two good practice recommendations
included in the guidelines:
 We recommend making health services inclusive of
men who have sex with men and transgender
people, based on the principles of medical ethics and
the right to health.
 We recommend that legislators and other
government authorities establish anti-discrimination
Table 2 Implications of a conditional recommendation
according to the factors that affected the strength and/or







local incidence of the
outcome of interest is
high enough to tip the
balance of benefits and




STIs using nucleic acid
amplification tests:
“The benefits increase as
the [HIV] prevalence
increases. The benefits
might outweigh the harms
and cost if prevalence of
asymptomatic urethral and








the effects of the
intervention
Targeted internet-based
strategies: “low quality of
evidence. . .studies were










conditional against in spite
of the possibility of benefits
outweighing harms:
“participants raised questions















require human resources for
implementation; this may
be a challenge in some
settings. For these




to the local context will be
necessary.”
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international human rights standards, in order inter
alia to eliminate discrimination and violence faced
by men who have sex with men and transgender
people, and reduce their vulnerability to infection
with HIV and the impacts of HIV and AIDS.
Wording of recommendations
Guideline panels present their judgments about the
quality of evidence and strength of recommendations
using specific wordings of the recommendation state-
ments and affixing grades to these statements (using a
combination of letters, numbers, and symbols) [45]. Un-
fortunately, there is little evidence of how well various
presentations are understood [45-47].
GRADE initially suggested to use the words ‘strong’ and
‘weak’ to characterize the strength of recommendations
[12]. It has become clear with experience that for certain
panelists ‘weak’ is not acceptable wording. Specifically,
public health guideline panels worry that policymakers
use this wording as an excuse to forgo the adoption of the
intervention being recommended. This is in spite of the
fact that a weak recommendation is intended to invite pol-
icymakers to involve their stakeholders in substantial de-
bate in considering the intervention (as opposed to a
strong recommendation intended to invite policymakers
to adopt the intervention as a policy) [12]. Thus, the
GRADE working group suggested alternatives to ‘weak’
such as ‘conditional’, ‘contingent’, and ‘qualified’. The core
guideline working group adopted the term ‘conditional’
and the panelists were very receptive.
The potential advantage of the term ‘conditional’ is
that it invites the user of the recommendation to con-
sider the implications of that term. ‘Conditional’ can
have four possible implications (or combinations of
these), depending on which factor(s) affected the strength
and/or direction of the recommendation (Additional file 3).
Table 2 provides the implications and examples for each
of these four factors.
The panel was also deliberately sensitive in wording
the statement of the recommendation. While typically a
recommendation would refer to the ‘use’ of a specific
intervention, the guideline recommendations refer to the
“offering” of an intervention. The intention was to avoid
the perception of coerciveness especially in settings
where MSM and transgender people are particularly
marginalized and at risk of stigma, violence and abuse.
Developing global guidelines
Developing guidelines with global scope is challenging,
whether the topic is of clinical or public health nature.
This may be particularly true for public health guidelines
to be adopted by different countries or by different juris-
dictions within a country. Indeed, the importance of theproblem (and consequently the size of the effects), and the
implications of an intervention (in terms of the availability
of resources, costs, cost-effectiveness, acceptability, and
feasibility) often vary substantially across settings.
In order to address this challenge, the survey of values
and preferences recruited participants globally. We priori-
tized evidence of effectiveness and of incidence of outcomes
from low- and middle-income countries when available.
Also, the panelists were asked to prioritize perspective of
low- and middle-income countries when making judgments
about values and preferences, feasibility and resource use.
Discussion
We identified and addressed a number of challenges
during the development of WHO guidelines for the pre-
vention and treatment of HIV and other STIs among
MSM and transgender people in the health sector in
low- and middle-income countries. While some of these
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guidelines (e.g., nature of the interventions, addressing
social and legal barriers) others are common to most
guidelines (e.g., adequacy of the evidence, indirectness of
the evidence, wording of the recommendations). Conse-
quently, the learning experience from this guideline may
benefit other fields.
We were able to address most of these challenges (e.g.,
indirectness of the evidence, values and preferences)
through using the principles of the GRADE approach.
The use of good practice recommendations and out-
come frameworks proved to be particularly useful. Suc-
cessfully overcoming some of the other challenges (e.g.,
scarcity of evidence) requires further research in the
field. Some other challenges require further methodo-
logical advancement (e.g., dealing with complex and
combined interventions). The GRADE working group
has been committed to and engaged in this process.
By requiring guideline developers to be systematic, ex-
plicit, and transparent in the assessment of the quality of
evidence, and in determining the strength of recommen-
dations, GRADE uncovers challenges such as those dis-
cussed in this paper. Indeed, these challenges relate to
the quality of available evidence and to the complexity
of guideline development process. The GRADE frame-
work continues to evolve to address some of the issues
specific to the field of public health.
One perceived limitation of the GRADE approach is
its involved handling of the evidence. However, the in-
volvement of a GRADE methodologist and the incre-
mental learning by the members of the core working
group have played a positive role. Also, using evidence
profiles and decision tables to summarize the informa-
tion should facilitate this process.
Finally, the GRADE approach can assist in resource
mobilization. Indeed, the representative of one of the
major funding bodies in the field declared at the end of
the meeting that their future funding, and as a result of
the rigorous process, will now take into consideration pa-
tient important outcomes such as quality of life and actual
incidence of HIV, instead of reported behavioral change.
Conclusion
We were able to successfully apply the GRADE approach
for developing recommendations for public health inter-
ventions. Applying the general principles of the GRADE
approach while carefully considering challenges specific to
the field of public health can enhance both the process
and the outcome of guideline development. Such an ap-
proach has the potential to move forward both the public
health practice and research.
Finally, the process highlighted the need for more re-
search both in the subject area (e.g., additional evaluation
of interventions, studies of transgender people, low andmiddle-income countries) and in the methodological area
(e.g., analysis of complex and combined interventions,
presentation and wording of recommendations).
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